Author:
Vandyke K,Jackson P,Rowe A,Russell P J,Blair J M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference43 articles.
1. Carlin BI, Andriole GL . The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 2000; 88: 2989–2994.
2. McMurtry CT, McMurtry JM . Metastatic prostate cancer: complications and treatment. J Am Geriatr Soc 2003; 51: 1136–1142.
3. Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ . Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 2001; 61: 4432–4436.
4. Penno H, Silfverswärd C-J, Frosta A, Brändström H, Nilsson O, Ljunggren Ö . Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. Biochem Biophys Res Commun 2002; 293: 451–455.
5. Pollen JJ, Reznek RH, Talner LB . Lysis of osteoblastic lesions in prostatic cancer: a sign of progression. AJR Am J Roentgenol 1984; 142: 1175–1179.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献